MetaVia MTVA
NASDAQ MTVA
$1.46 +0.02 (+1.39%)
At close: Aug 21, 2026 · 4:00 PM EDT

MetaVia (MTVA) Net Cash Flow (2015 - 2025)

MetaVia's (MTVA) quarterly Net Cash Flow came in at -$4.0 million in Q4 2025, up 29.25% YoY from -$3.1 million in Q4 2024, and down 20.74% on a QoQ basis from -$3.3 million in Q3 2025.

MetaVia (MTVA) Net Cash Flow (2015 - 2025) Analysis & Trends

MetaVia (MTVA) has 11 years of Net Cash Flow data on file, last reported at -$4.0 million in Q4 2025.

  • Quarterly Net Cash Flow rose 29.25% year-over-year to -$4.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$5.7 million (up 77.61% YoY) and the FY2025 annual result came in at -$5.7 million, up 10.58% from the prior year.
  • Net Cash Flow slipped to -$4.0 million in Q4 2025, from -$3.3 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $27.0 million in Q4 2022 to a low of -$7.3 million in Q2 2024.
  • A 5-year average of -$939600.0 and a median of -$3.1 million in 2023 frame the typical range for Net Cash Flow.
  • Annual changes were most pronounced in 2021 — Net Cash Flow soared 513.0% — and 2022, when it tumbled 263.64%.
  • Tracing MTVA's Net Cash Flow over 5 years: stood at $9.4 million in 2021, then surged by 187.2% to $27.0 million in 2022, then plunged by 112.6% to -$3.4 million in 2023, then sank by 66.14% to -$5.7 million in 2024, then gained by 29.25% to -$4.0 million in 2025.
  • The last three Net Cash Flow figures came in at -$4.0 million (Q4 2025), -$3.3 million (Q3 2025), and $6.4 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 652.90 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -504.30 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -183.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 407.41 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -496,000.00
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -2.83 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -37.14 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 225.59 Mn
10 MetaVia 8.72 Mn -3.92 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 -4.00 Mn
Dec 31, 2025 -4.00 Mn
Sep 30, 2025 -3.31 Mn
Sep 30, 2025 -3.31 Mn
Jun 30, 2025 6.39 Mn
Jun 30, 2025 6.39 Mn
Mar 31, 2025 -4.81 Mn
Mar 31, 2025 -4.81 Mn
Dec 31, 2024 -5.65 Mn
Dec 31, 2024 -5.65 Mn
Sep 30, 2024 -6.27 Mn
Sep 30, 2024 -6.27 Mn
Jun 30, 2024 -7.25 Mn
Jun 30, 2024 -7.25 Mn
Mar 31, 2024 -6.45 Mn
Mar 31, 2024 -6.45 Mn
Dec 31, 2023 -3.40 Mn
Dec 31, 2023 -3.40 Mn
Sep 30, 2023 -2.85 Mn
Sep 30, 2023 -2.85 Mn